ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
FDA approval for Pitt Hopkins syndrome IND and Phase 2 trial
Published: 25/03/22, 09:54am (AEST)•2 pages